Influence of fingolimod on basic lymphocyte subsets frequencies in the peripheral blood of multiple sclerosis patients – preliminary study

BACKGROUND: Fingolimod is a drug administered orally to adult patients treated for relapsing remitting course of multiple sclerosis (MS). Mode of action of fingolimod is based on intense S1P1 receptor stimulation and “arresting” lymphocytes in lymphatic organs. Objective of the research was to asses...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cent Eur J Immunol
Autors principals: Rudnicka, Julia, Czerwiec, Michał, Grywalska, Ewelina, Siwicka-Gieroba, Dorota, Walankiewicz, Monika, Grafka, Agnieszka, Zgurski, Michał, Surdacka, Agata, Bartosik-Psujek, Halina, Roliński, Jacek
Format: Artigo
Idioma:Inglês
Publicat: Polish Society of Experimental and Clinical Immunology 2015
Matèries:
Original Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4655387/
https://ncbi.nlm.nih.gov/pubmed/26648781
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/ceji.2015.54599
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars